CoChat

Chronic Fluoxetine Treatment Induces Brain Region-Specific Upregulation of Genes Associated with BDNF-Induced Long-Term Potentiation

Open access

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Abstract

Several lines of evidence implicate BDNF in the pathogenesis of stress-induced depression and the delayed efficacy of antidepressant drugs. Antidepressant-induced upregulation of BDNF signaling is thought to promote adaptive neuronal plasticity through effects on gene expression, but the effector genes downstream of BDNF has not been identified. Local infusion of BDNF into the dentate gyrus induces a long-term potentiation (BDNF-LTP) of synaptic transmission that requires upregulation of the immediate early gene Arc. Recently, we identified five genes (neuritin, Narp, TIEG1, Carp, and Arl4d) that are coupregulated with Arc during BDNF-LTP. Here, we examined the expression of these genes in the dentate gyrus, hippocampus proper, and prefrontal cortex after antidepressant treatment. We show that chronic, but not acute, fluoxetine administration leads to upregulation of these BDNF-LTP-associated genes in a brain region-specific pattern. These findings link chronic effects of antidepressant treatment to molecular mechanisms underlying BDNF-induced synaptic plasticity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2007/26496

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Chronic fluoxetine administration leads to brain region-specific upregulation of LTP-associated genes. Changes in mRNA expression following fluoxetine treatment are expressed as fold change relative to the saline control group. (a) Prefrontal cortex, (b) hippocampus proper, (c) dentate gyrus. N=7 fluoxetine chronic, n=8 NaCl chronic, n=5 fluoxetine acute, n=4 NaCl acute (except neuritin chronic NaCl in DG, n=7). *P<.05, **P<.01, **P<.001 from Student's t-test.
Figure 1 Chronic fluoxetine administration leads to brain region-specific upregulation of LTP-associated genes. Changes in mRNA expression following fluoxetine treatment are expressed as fold change relative to the saline control group. (a) Prefrontal cortex, (b) hippocampus proper, (c) dentate gyrus. N=7 fluoxetine chronic, n=8 NaCl chronic, n=5 fluoxetine acute, n=4 NaCl acute (except neuritin chronic NaCl in DG, n=7). *P<.05, **P<.01, **P<.001 from Student's t-test.CC BY · PubMed Central
Figure 2 Brain region-specific upregulation of BDNF exon-III specific mRNA in chronic fluoxetine-treated rats. (a) Prefrontal cortex, (b) hippocampus proper, (c) dentate gyrus. N=7 fluoxetine chronic, n=8 NaCl chronic, n=5 fluoxetine acute, n=4 NaCl acute. *P<.05, **P<.01 Student's t-test.
Figure 2 Brain region-specific upregulation of BDNF exon-III specific mRNA in chronic fluoxetine-treated rats. (a) Prefrontal cortex, (b) hippocampus proper, (c) dentate gyrus. N=7 fluoxetine chronic, n=8 NaCl chronic, n=5 fluoxetine acute, n=4 NaCl acute. *P<.05, **P<.01 Student's t-test.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 62 references

Research works printed but not linked: 3

  1. 2006, Current Opinion in Drug Discovery and Development, 9, 580
  2. 10.1002/(sici)1097-4695(199904)39:1<41::aid-neu4>3.0.co;2-x · DOI · Paper page
  3. 2002, The Journal of Neuroscience, 22, 1532, 10.1523/jneurosci.22-05-01532.2002 · DOI · Paper page

Cited by

See all 109

Metadata

Authors
Alme, M. N., Wibrand, K., Dagestad, G., & Bramham, C. R.
Affiliations
University of Bergen (NO)
Corresponding author
Bramham, Clive R.
Venue
Neural Plasticity
Publisher
Wiley
Published
2007
Volume
2007
Pages
1-9
ISSN
  • 1687-5443 (ISSN-L)
  • 2090-5904
OpenAlex
W1995360320
Cited by
103
References
62
Citations by year
2026: 2 · 2025: 4 · 2024: 5 · 2023: 1 · 2021: 8 · 2020: 3 · 2019: 2 · 2018: 5 · 2017: 8 · 2016: 7 · 2015: 10 · 2014: 4 · 2013: 7 · 2012: 8
FWCI
4.68
Type
journal article
Language
en
Open access
Locations
  • Neural Plasticity (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • The Research Council (504231)
  • Marie Curie Research Training Networks (504231)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
fluoxetine, brain-derived neurotrophic factor, long-term potentiation, Arc, neuritin, NARP, TIEG1, carp, antidepressant efficacy, stress-induced depression, synaptic plasticity, hippocampus, dentate gyrus, prefrontal cortex, gene expression, brain region specificity
MeSH terms
Pentraxins, Animals, Brain, C-Reactive Protein, Carrier Proteins, Depressive Disorder, DNA-Binding Proteins, Drug Administration Schedule, Drug Resistance, Fluoxetine, Gene Expression Regulation, Male, Nerve Tissue Proteins, Neuropeptides, Phosphoproteins, Stress, Psychological, Time Factors, Transcription Factors, Up-Regulation, Selective Serotonin Reuptake Inhibitors, Long-Term Potentiation, Brain-Derived Neurotrophic Factor, ADP-Ribosylation Factors, Rats, GPI-Linked Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chronic Fluoxetine Treatment Induces Brain Region-Specific Upregulation of Genes Associated with BDNF-Induced Long-Term Potentiation. https://app.cochat.ai/papers/10.1155/2007/26496
The paper
Alme, M. N., Wibrand, K., Dagestad, G., & Bramham, C. R. (2007). Chronic Fluoxetine Treatment Induces Brain Region-Specific Upregulation of Genes Associated with BDNF-Induced Long-Term Potentiation. Neural Plasticity. https://doi.org/10.1155/2007/26496

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.